Bristol-Myers Squibb Co news

   Watch this stock
Showing stories 1 - 10 of about 177   

Articles published

BMY 61.45 +0.94 (1.55%)
price chart
Lamberto Andreotti Insider Trade for 23200 Shares of Bristol-Myers Squibb Co ...
After the publishing of a legal report filled with (SEC); a insider transaction became apparent. The director of Bristol-Myers Squibb Co (NYSE:BMY) 60.51 -0.04 -0.07% , Lamberto Andreotti; completed a transaction in the open market by unloading 23,200 ...
Bristol-Myers Squibb paying $14.6M to settle SEC charges over payments to win ...
The Securities and Exchange Commission announced the settlement of civil charges Monday with the company, one of the largest drugmakers in the world.
Shares of Bristol-Myers Squibb Company (NYSE:BMY) Sees Large Inflow of Net Money  News Watch International
Bristol-Myers Squibb Company (NYSE:BMY) Analyst Price Target  Money Flow Index
Insider Selling: Bristol-Myers Squibb Director Sells 23200 Shares of Stock (BMY)
Bristol-Myers Squibb logo Bristol-Myers Squibb (NYSE:BMY) Director Lamberto Andreotti sold 23,200 shares of the company's stock in a transaction dated Tuesday, October 6th. The shares were sold at an average price of $60.86, for a total value of ...
Bristol-Myers Squibb Given Buy Rating at William Blair (BMY)  Dakota Financial News
Large Inflow of Money Witnessed in Bristol-Myers Squibb Company  Insider Trading Report
November 27th Options Now Available For Bristol-Myers Squibb (BMY)
Investors in Bristol-Myers Squibb Co. (NYSE: BMY) saw new options begin trading today, for the November 27th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BMY options chain for the new November 27th ...
Insider Selling:, Inc, Bristol-Myers Squibb Co, RSP Permian Inc ...
Bidness Etc talks about the recent insider selling at, inc. (NYSE:CRM), Bristol-Myers Squibb Co (NYSE:BMY) and RSP Permian Inc (NYSE:RSPP).
UBS Upgrades Bristol-Myers Squibb Co. (BMY) to Buy; More Bullish on Opdivo
UBS upgraded Bristol-Myers Squibb Co. (NYSE: BMY) from Neutral to Buy with a price target of $75.00 (from $65.00), saying they like the opportunity "right here, right now.
Analysts at UBS Securities Upped Bristol-Myers Squibb Company (NYSE:BMY ...
Large Outflow of Money Witnessed in Bristol-Myers Squibb Company  Insider Trading Report
Bristol-Myers Squibb Co (BMY) Takeover Speculation. Wall Street Buys Calls
Bristol-Myers Squibb Co (NYSE:BMY) October 62.5 and 67.5 calls are active on total call volume of 39K compare to 11K puts on the subject of takeover speculation.
Options Bulls Take Notice as Bristol-Myers Squibb Co (BMY) Pushes Higher  Schaeffers Research (blog)
Storm The Castle: Bristol-Myers Squibb Company (BMY)
Bristol-Myers Squibb Co (BMY) Stock Market News
Bristol-Myers announced that the FDA approved Opdivo nivolumab in combination with Yervoy ipilimumab -, for the treatment of patients with BRAF V600 wild-type unresectable or metastatic melanoma.
Bristol-Myers Squibb Co Surges On FDA Approval For Cancer Drug  Bidness ETC
Bristol-Myers Squibb Receives Approval from the US Food and Drug ...  FiercePharma
Bristol-Myers Squibb Co To Join HCV Drug Race Soon; Daklinza sNDAs Win FDA ...
Bristol-Myers Squibb Co. (NYSE:BMY) announced Tuesday that the Food and Drug Administration (FDA) has agreed to review all three supplemental New Drug Applications (sNDAs) for its drug Daklinza.
Traders Alert on Notable Stocks: SandRidge Energy (NYSE:SD), Bristol-Myers ...  wsnewspublishers
Bristol-Myers Squibb's Daklinza to treat HCV gets US FDA Priority Review ...
Bristol-Myers Squibb's Kidney Opportunity Is Bigger Than Some Thought
A couple of months ago, Bristol-Myers released positive top-line kidney cancer data, but investors did not seem to care much, focusing instead on lung cancer.
Zacks Short Term Rating on Bristol-Myers Squibb Company  News Watch International
Hot News Report on: General Electric Company (NYSE:GE), Bristol-Myers Squibb ...  wsnewspublishers